Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone for chronic lung disease of prematurity in school-aged children
ACTRN12618000781246Phase 4Completed
- Sponsor
- Kids Research Institute Australia
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing Fluticasone propionate with Placebo inhaler (2 arms). Primary endpoint: Change in forced expiratory volume in 1 second. Started Oct 2018; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on ACTRN12618000781246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000781246.